Clinical trials
Completed trials in Colombia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,399 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 4 |
| 2002 | 9 |
| 2003 | 20 |
| 2004 | 22 |
| 2005 | 28 |
| 2006 | 45 |
| 2007 | 57 |
| 2008 | 63 |
| 2009 | 76 |
| 2010 | 70 |
| 2011 | 101 |
| 2012 | 66 |
| 2013 | 72 |
| 2014 | 72 |
| 2015 | 72 |
| 2016 | 75 |
| 2017 | 82 |
| 2018 | 87 |
| 2019 | 74 |
| 2020 | 74 |
| 2021 | 60 |
| 2022 | 53 |
| 2023 | 45 |
| 2024 | 40 |
| 2025 | 17 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,399 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 105 |
| Pfizer | 79 |
| Sanofi | 56 |
| AstraZeneca | 54 |
| Hoffmann-La Roche | 54 |
| Bayer | 53 |
| Merck Sharp & Dohme LLC | 52 |
| Universidad de Antioquia | 50 |
| GlaxoSmithKline | 33 |
| Bristol-Myers Squibb | 32 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Rheumatoid | 64 |
| Diabetes Mellitus, Type 2 | 61 |
| Breast Neoplasms | 43 |
| COVID-19 | 43 |
| Asthma | 35 |
| Pulmonary Disease, Chronic Obstructive | 32 |
| Lupus Erythematosus, Systemic | 29 |
| Carcinoma, Non-Small-Cell Lung | 23 |
| Cardiovascular Diseases | 21 |
| Hypertension | 21 |
Trials
Showing 1 to 25 of 1,399. Each trial links to its page on Pharma Observatory.
1,299 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.